Table 5: VAP development condition with uncontrolled and controlled groups according to introductory features.
| VAP Development Condition |
| Uncontrolled Group | Controlled Group |
| Yes | No | Yes | No |
| n (%) | n (%) | n (%) | n (%) |
| Gender | Female | 4 (40.0) | 16 (39.2) | - | 10 (24.4) |
| Male | 6 (60.0) | 25 (60.8) | 2 (100) | 31 (75.6) |
| Test and p value | X2*=0.003; p=1.000 | X2=0.636; p=1.000 |
| Previous Clinic | Emergency | 6 (60.0) | 13 (31.7) | 2 (100) | 14 (34.1) |
| Intra-Hospital Clinic | 3 (30.0) | 23 (56.1) | - | 26 (63.4) |
| Intra-Hospital Another ICU | 1 (10.0) | 5 (12.2) | - | 1(2.5) |
| Test and p value | X2=3.540; p=0.170 | X2=2.834; p=0.242 |
| Reason of Hospitalization | Trauma | - | 2 (4.9) | 1 (50) | 3 (7.3) |
| Postop | 4(40) | 5 (12.2) | - | 7 (17.1) |
| Internaldiseases | 6 (60) | 34 (82.9) | 1 (50) | 31(75.6) |
| Test and p value | X2=4.549; p=0.103 | X2=4.244; p=0.120 |